Time for Resolution of COVID-19 Vaccine–Related Axillary Lymphadenopathy and Associated Factors
Elizabeth G. Lane, Carolyn S. Eisen, Michele Drotman, Katerina Dodelzon, Eralda Mema, Charlene Thomas, Martin R. Prince
Abstract
The prolonged time to resolution supports not delaying screening mammography because of recent COVID-19 vaccination. It also supports the professional society recommendation of a follow-up interval of at least 12 weeks when vaccine-related lymphadenopathy is suspected.
Topics & Concepts
MedicineAxillary LymphadenopathyCervical lymphadenopathyUltrasoundLymph nodeRetrospective cohort studySubclinical infectionRadiologyAxillaVaccinationBreast cancerNuclear medicineSurgeryInternal medicinePathologyCancerDiseaseLymphadenopathy Diagnosis and AnalysisLymphoma Diagnosis and TreatmentSoft tissue tumors and treatment